PUBLICATIONS

  1. Porterfield LM. Geriatric pharmacology: Therapeutic rationale. Home Healthcare Nurse. 1984;2:23-35.
  2. Porterfield LM and Harris B. Informal needs of the pregnant adolescent. Home Healthcare Nurse. 1985;3:40-42.
  3. Porterfield LM. Digoxin-drug interactions.  Home Healthcare Nurse. 1985;3:11-15.
  4. Porterfield LM. Will the real nurse please stand up. RN. 1986; May:65-66.
  5. Porterfield LM, Porterfield JG and Brown S. Sudden cardiac death. Focus on Critical Care. 1986;13:23-31.
  6. Porterfield LM and Porterfield JG. What you need to know about today's pacemakers. RN. 1987;March:44-49.
  7. Porterfield LM. Getting published. Nursing Life. 1987;7:20-21.
  8. Porterfield LM, Porterfield JG and Duvall C. Insertion of a permanent pacemaker. Critical Care Nurse. 1987;7:30-34.
  9. Porterfield LM. Care of the retarded child. AD Nurse. 1987;2:5-7.
  10. Porterfield LM, Tucker BD and Caldwell RW. Binding of ouabain to isolated, adult dog heart cells: Effects of Na+-pump and contractility. In Biology of the Isolated Adult Cardiac Myocyte, Ed. A. Ross, Elseiver Publishing Co., Inc.; 1988.
  11. Porterfield JG and Porterfield LM.  Therapeutic efficacy and safety of oral propafenone for atrial fibrillation.  Am J Cardiol. 1989; 63:114-116
  12. Porterfield LM and Porterfield JG. How digoxin interacts with other drugs: a practical guide. Nursing 90. January:50-51.
  13. Porterfield LM.  Writing, getting your work published.  In Nurse's Quick Reference, Ed. Susan L. Jackson, Springhouse Corporation, Pennsylvania, 1990.
  14. Porterfield LM.  How to get published.  Nursing. 90; July:95.
  15. Porterfield LM and Porterfield JG.  Understanding cardiovascular drug interactions.  Focus on Critical Care. 1990;17:412-416.
  16. Porterfield LM and Porterfield JG.  Heart block post MI.  Critical Care Nurse.1991;11(9):72-64.
  17. Porterfield JG, Porterfield LM, and Bray L.  Long term community hospital experience with the internal defibrillator.  PACE. 1991; 14:263-266. 
  18. Porterfield JG, Porterfield LM, Bray L, and Sugalski J.  A prospective study utilizing a transtelephonic electrocardiographic transmission program to manage patients the first several months post AICD implant.  PACE. 1991;14:308-311.
  19. Porterfield JG, Porterfield LM, and Bray L.  Ninety-six episodes of spontaneous ventricular tachycardia in one week:  success of ramp pacing by an implanted pacer-cardioverter-defibrillator.  PACE. 1991;14:1440-1443.
  20. Porterfield LM.  The country woman. In Nurse, Hearts and Hands, Ed.  William H. Hull, Stanton Publications, Minneapolis, 1991.
  21. Porterfield LM and Porterfield JG.  RM: Automatic cardioverter defibrillator. Critical Care Nurse. 1992;12(1):13-14.
  22. Porterfield JG, Porterfield LM, Strong SB.  Propafenone therapy for malignant ventricular arrhythmias.  J Invas Cardiol. 1992; 4(3):131-135.
  23. Porterfield JG and Porterfield LM.  Signal-averaged electrocardiograms; a new noninvasive tool to identify patients at risk for sudden cardiac death.  Patient Care. 1993;Jan 30:73-80.
  24. Porterfield LM and Porterfield JG. Radiofrequency ablation of a left-sided free-wall accessory pathway: A case study.  Critical Care Nurse. 1993; 13: 46-49.
  25. Porterfield JG, Porterfield LM, Smith BA, et al.  Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator.  PACE. 1993;16(1):170-173.
  26. Porterfield LM, Porterfield JG, Collins SW.  The cutting edge in arrhythmias.  Critical Care Nurse. 1993; Suppl. June: 8-9.
  27. Porterfield JG, Porterfield LM, Smith BA, Bray L.  Experience with three different third generation cardioverter defibrillators in patients with coronary artery disease or cardiomyopathy.  Am J Cardiol. 1993;72(3)301-304.
  28. Porterfield, JG Porterfield, LM Snell J.  The usefulness of the third generation defibrillator for the management of a patient with recurrent ventricular arrhythmias.  J Invas Cardiol. 1993;5(8) 315-318.
  29. Porterfield, LM.  A bleak future for new drugs and devices.  Tennessee Nurse. 1993; 56(2): 9.
  30. Porterfield LM and Porterfield JG.  Digitalis overdose:  A common occurrence.  Critical Care Nurse. 1993; 13(6):40-43.
  31. Porterfield LM. Commitment to nursing.  RN. 1993; November: 88.
  32. Porterfield JG and Porterfield LM. A new approach: A single triple electrode system interfaced with a third generation defibrillator. J Invas Cardiol. 1994; 6:246-250.
  33. Porterfield LM, Porterfield JG, and Eppes D. Know your defibrillator: An instructional computer program. Cath-Lab Digest. 1994; 2:10.
  34. Porterfield LM and Porterfield JG.  Third generation cardioverter-defibrillator:  A case study.  Critical Care Nurse. 1995; 15:43-45.
  35. Porterfield JG, Porterfield LM, Fiallo LA. Management of ventricular tachycardia with ablation therapy in a patient with a previously implanted cardioverter defibrillator. J Invas Cardiol
  36. 1995; 7: 53-56.
  37. Porterfield JG, Porterfield LM, Ali M. Arrhythmia after emergency CABG. Patient Care. 1995; 29:74-75.
  38. Porterfield JG and Porterfield LM. ECG Case and Comment:  Dig those crazy rhythms. Patient Care. 1995; 29: 158-159.
  39. Porterfield JG and Porterfield LM.  ECG Case and Comment:  A "shock" to the system.  Patient Care. 1995; 29: 181-182.
  40. Porterfield JG, Porterfield LM, Rice KM.  ECG Case and Comment:  Refractory atrial fibrillation what next?  Patient Care.  1995; 29:  90-92. 
  41. Porterfield, LM, Jaster JH, Bertorini TE, et al. Cardiac arrest following vertebrobasilar stroke. J Tenn Med Assoc. 1995; 88:309.
  42. Porterfield JG and Porterfield LM. The evolution of implantable defibrillator technology.  Primary Cardiology. 1995; 21:24-32.    
  43. Porterfield, LM, Jaster JH, Bertorini, TE, et al. Stroke and cardiac arrest (Letter).  Neurology.  1996; 47:1357.
  44. Porterfield JG, Porterfield LM, Levine JH, et al.  Compatibility of a nonthoracotomy lead system with a biphasic implantable cardioverter-defibrillator.  Am J Cardiol. 1996; 77:586-590.
  45. Mahajan S, Porterfield JG, Porterfield LM, Wells VE and Crump CA. The shocking lung mass: A case report. PACE. 1996; 19: 1398-1399.
  46. Bardy GH, Yee R, Jung W for the Active Can Investigators.  Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator.  J Am Coll Cardiol.  1996;28:400-410.
  47. Porterfield JG, Porterfield LM, Ali M.  ECG Case and Comment: A cure for a common arrhythmia. Patient Care:  1996; 30: 222-228.
  48. Porterfield JG, Porterfield LM, Mahajan S. A systemic approach to a medical emergency. Patient Care 1997;31:184-186.
  49. Porterfield, LM [Consultant].  ECG Interpretation Made Incredibly Easy Springhouse, PA:  Springhouse Corp., 1997.
  50. Porterfield, LM [Contributor].  ECG Interpretation Made Incredibly Easy  Springhouse, PA: Springhouse Corp., 1997.
  51. Porterfield, LM.  Forward.  ECG Interpretation Made Incredibly Easy Springhouse, PA: Springhouse Corp, 1997.
  52. Porterfield JG, Porterfield LM, Boko TE.  Multiple, mysterious syncopal episodes.  Patient Care 1998;32:185-187.
  53. Porterfield JG, Porterfield LM, Nestor JR.  Daily variations in the occurrence of symptomatic supraventricular tachycardia as determined by ambulatory event monitoring.  Am J Cardiol 1998;80:889-891.
  54. Porterfield JG, Porterfield LM.  Unexplained Syncope:  What to expect from loop recorders.  The Journal of Noninvasive Cardiology. 1998; 3(3):91-94.
  55. Porterfield JG, Porterfield LM, and Khattak T.  A syncopal episode. Patient Care 2000; 34: 137-139.
  56. Porterfield, JG, Menon V. Porterfield, LM.  Should a patient with an internal defibrillator drive?  Patient Care 2000; 34: 73-74.
  57. Porterfield JG, Porterfield LM, Khattak TA.  Uncommon reaction to a commonly used antibiotic.  Patient Care 2000; 34: 138-139.
  58. Porterfield JG, Khattak TA, and Porterfield LM.  Neurologic deficit in a patient with a pacemaker.  Patient Care 2001; 35:98-99.
  59. Watson AT, Porterfield JG, Porterfield LM.  Sudden cardiac death in a patient with palpitations.  Patient Care 2001; 35: 77-79.
  60. Lofton B, Porterfield JG, Porterfield LM.  Idiopathic right sided ventricular tachycardia.  Patient Care (In Press).
  61. Shaikh K, Porterfield JG, Porterfield LM.  Inappropriate sinus tachycardia.  Patient Care (In Press).

(Abstracts):

  1. Porterfield LM, Songu-Mize E, Chryssanthis T and Caldwell RW. Action of ouabain and an amino-cardenolide on Na+-pump function and contractility of isolated canine heart cells. Fed Proc. 1986; 45:811.
  2. Porterfield LM, Chryssanthis MA, Weiss MT and Caldwell RW. Binding and actions of a polar aminocardenolide, ASI-222, to isolated heart cells. Circulation. 1986;74:319
  3. Caldwell RW, Porterfield LM and Nash CB.  Actions of an aminocardenolide and ouabain on A-V nodal refractory period. The  Pharmacologist. 1986;28:218.
  4. Porterfield LM, Tucker BD and Caldwell RW. Binding of ouabain to isolated canine heart cells and effect on Na+-pump and contractility. Fed Pro. 1987;46:560.
  5. Porterfield LM, Chryssanthis MA, Williams RE and Caldwell RW. The binding characteristics and functional responses of ASI-222 in isolated Ca++-tolerant canine cardiac myocytes.  The Pharmacologist. 1987;29:165.
  6. Winkle RA, Fain ES, Sweeney MB, Senelly KM, and the Cadence Investigators. Survival in patients with ventricular arrhythmias treated with programmable tiered therapy implantable defibrillators.  JACC. 1992;19(3):209A.
  7. Winkle RA, Fain ES, Hardage ML, Senelly KM, and the Cadence Investigators.  The value and usage of programmability in a tiered therapy defibrillator.  JACC. 1992;19(3):365A.
  8. Rahul Mehra, Norenberg MS, Degroot P, PCD Investigators.  Multicenter Clinical results with an implantable defibrillator utilizing transvenous leads.  PACE. 15(4);566:1992.
  9. Porterfield JG, Porterfield LM, Smith BA, et al.  Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator.  EUR JCPE. 2(2), 118A; 1992.
  10. Porterfield JG, Porterfield LM, Smith BA et al. Clinical experience with three different third generation cardioverter defibrillators.  EUR JCPE 2(2), 120A: 1992.
  11. Steinhaus DM, Foley L, Knoll K and PCD Investigators.  Non-thoracotomy defibrillator systems: who is a candidate?  PACE 1994;16(4):185.
  12. Porterfield LM, Porterfield JG, Eppes D, et al.  Know Your Defibrillator: An instructional computer program.  JACC February, 384A: 1994.
  13. Porterfield JG, Porterfield LM, Levine J, Luceri RM, Hsai HH. and the Cadence/Endotak IDE Investigators. A prospective study analyzing the safety and efficacy of interfacing a triple electrode defibrillation lead system with a tiered therapy device. Circulation; 90: 497;1994.
  14. Porterfield JG and Porterfield LM. Circadian patterns of 3,087 patients with supraventricular tachycardias.  JACC; 27:399A; 1996. 
  15. Porterfield LM, Porterfield JG and Eppes D.  Know Your Heart: An instructional computer program.  National Teaching Institute Proceedings, 94:1996.
  16. Porterfield JG, Porterfield LM, Easley A, et al.  Transtelephonic ICD follow-up:  a new patient-management tool.  PACE; 20 (Part II): 633, 1997.
  17. Porterfield JG, Porterfield LM and Nestor JR.  Unexplained syncope:  What to expect from loop recorders.  Archives des malades du Coeur et des Vaisseaux; 91: 197; 1998.
  18. Porterfield JG, Porterfield LM, Roberts DM, and Butze EA.  Long-term performance of on transvenous lead system for implantable cardioverter-defibrillators. EUROPACE 2000; 1: 209 D.
  19. Porterfield JG, Porterfield LM, Butze EA, Bryant JL.  Fourteen year experience in patients with implantable cardioverter-defibrillators.  PACE; 24 (Part II):674, 2001.
  20. Porterfield, LM [Consultant].  ECG Interpretation Made Incredibly Easy 2nd ed. Springhouse, PA: Springhouse, 2002.
  21. Porterfield, LM [Contributor].  ECG Interpretation Made Incredibly Easy 2nd ed.  Springhouse, PA: Springhouse, 2002
  22. Porterfield, LM.  Forward.  ECG Interpretation Made Incredibly Easy 2nd ed. Springhouse, PA: Springhouse, 2002.